In contrast to the control group, all SCH treatment groups demonstrated a significant increase (p < 0.05, p < 0.01, p < 0.0001) in serum IgM and IgG concentrations Figure 4C,D. This evidence concerns the gene CD40LG and spindle cell hemangioma.